HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Calverley Selected Research

Therapeutics

2/2004COPD exacerbations: the importance of a standard definition.
1/2003Conclusion. Lessons from the novel D2 dopamine receptor, beta2-adrenoceptor agonist, Viozan: chronic obstructive pulmonary disease and drug development implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Calverley Research Topics

Disease

6Chronic Obstructive Pulmonary Disease (COPD)
07/2009 - 01/2003
1Cardiovascular Diseases (Cardiovascular Disease)
05/2006
1Obstructive Lung Diseases (Obstructive Lung Disease)
05/2006
1Dyspnea (Shortness of Breath)
04/2005
1Insulin Resistance
11/2001

Drug/Important Bio-Agent (IBA)

2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2009 - 04/2005
1IrbesartanFDA LinkGeneric
05/2006
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2006
1Cardiovascular AgentsIBA
05/2006
1Angiotensin Receptor AntagonistsIBA
05/2006
1Angiotensin IIIBA
05/2006
1Angiotensin Receptors (Angiotensin II Receptor)IBA
05/2006
1Formoterol Fumarate (Oxis)FDA Link
09/2005
1Budesonide (Pulmicort)FDA LinkGeneric
09/2005
1Fluticasone (Cutivate)FDA LinkGeneric
04/2005
1Salmeterol Xinafoate (Serevent)FDA Link
04/2005
1Dopamine Receptors (Dopamine Receptor)IBA
01/2003
1sibenadet (Viozan)IBA
01/2003
1Dopamine (Intropin)FDA LinkGeneric
01/2003
1LeptinIBA
11/2001
1Growth Hormone (Somatotropin)IBA
11/2001
1LipidsIBA
11/2001

Therapy/Procedure

2Therapeutics
02/2004 - 01/2003